“The darkest hour is just before the dawn,” says Rupert Thompson of Kingswood. British shares shrugged off this week’s new lockdown, with the FTSE 100 gaining almost 2% in the first two days of the year. The short-term news is dire, but investors are concentrating on the vaccine rollout, which should pave the way for a return to normal. Provided the vaccination campaign continues without any serious glitches then traders will remain bullish.
The Brexit deal was met with relief. With no-deal uncertainty finally out of the way another key headwind has been removed for UK shares. The index has plenty of room to rise after turning in an abysmal performance last year, falling by 14.3% for its worst showing since 2008. The FTSE 100 has underperformed for some time, notes Stefan Wagstyl in the Financial Times. Since 2016 it has gained less than 8%, compared with a 44% rise in German markets. British shares finally picked up in October, with the FTSE 250 up by 22% since then. That isn’t just vaccine euphoria. It also reflects hope that with the post-Brexit outlook clearer business investment will soar.
Try 6 free issues of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Sign up for MoneyWeek’s free twice-daily newsletter.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.